Acurx Pharmaceuticals Receives FDA Conditional Acceptance and USPTO Trademark Allowance for the Company's Brand Name for Ibezapolstat
PR Newswire•17/08/2026•08:01 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.